JNJ-55308942 | Interleukin Related interleukin-related.com

Product Name :
JNJ-55308942

Search keywords :
JNJ-55308942

drugId :
null

Target Vo:
P2X purinoceptor 7

Target Vo Short Name :
P2RX7

Moa_Name:
P2X purinoceptor 7 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson Innovative Medicine

Active Company_Name :
Janssen Pharmaceutical Nv

Active Indication_Name:
Bipolar Disorder

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IL-1 beta Antibody (YA345)
FAK Antibody
Acetyl-Histone H3 (Lys27) Antibody: Acetyl-Histone H3 (Lys27) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Acetyl-Histone H3 (Lys27). It can be used for WB,IHC-F,IHC-P,ICC/IF,IP,ChIP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts